Page 143 - 南京医科大学自然版

第45卷第2期 陆瑄贝，王晓东. 甲状腺激素与心脏纤维化研究进展［J］.
2025年2月 南京医科大学学报（自然科学版），2025，45（2）：278-284 ·283 ·

myocardial disease［J］. Nat Rev Cardiol，2022，19（7）： ol，2020，11：529075
435-455 ［34］LI Y Y，FENG Y Q，KADOKAMI T，et al. Myocardial ex⁃
［21］LIU C，LIM S T，TEO M H Y，et al. Collaborative regula⁃ tracellular matrix remodeling in transgenic mice overex⁃
tion of LRG1 by TGF⁃β1 and PPAR⁃β/δ modulates chron⁃ pressing tumor necrosis factor alpha can be modulated by
ic pressure overload ⁃ induced cardiac fibrosis［J］. Circ anti ⁃ tumor necrosis factor alpha therapy［J］. Proc Natl
Heart Fail，2019，12（12）：e005962 Acad Sci U S A，2000，97（23）：12746-12751
［22］PENG D，FU M，WANG M，et al. Targeting TGF⁃β signal ［35］DÍEZ J J，HERNANZ A，MEDINA S，et al. Serum concen⁃
transduction for fibrosis and cancer therapy［J］. Mol Can⁃ trations of tumour necrosis factor⁃alpha（TNF⁃alpha）and
cer，2022，21（1）：104 soluble TNF⁃alpha receptor p55 in patients with hypothy⁃
［23］ALONSO ⁃ MERINO E，MARTÍN OROZCO R，RUÍZ ⁃ roidism and hyperthyroidism before and after normaliza⁃
LLORENTE L，et al. Thyroid hormones inhibit TGF⁃β sig⁃ tion of thyroid function［J］. Clin Endocrinol（Oxf），2002，
naling and attenuate fibrotic responses［J］. Proc Natl 57（4）：515-521
Acad Sci U S A，2016，113（24）：E3451-E3460 ［36］MARCHIORI R C，PEREIRA L A F，NAUJORKS A A，et
［24］ANTAR S A，ASHOUR N A，MARAWAN M E，et al. Fi⁃ al. Improvement of blood inflammatory marker levels in
brosis：types，effects，markers，mechanisms for disease patients with hypothyroidism under levothyroxine treat⁃
progression，and its relation with oxidative stress，immuni⁃ ment［J］. BMC Endocr Disord，2015，15：32
ty，and inflammation［J］. Int J Mol Sci，2023，24（4）：4004 ［37］KUZMAN J A，O'CONNELL T D，GERDES A M. Rapa⁃
［25］DIMAURO I，PARONETTO M P，CAPOROSSI D. Exer⁃ mycin prevents thyroid hormone⁃induced cardiac hyper⁃
cise，redox homeostasis and the epigenetic landscape［J］. trophy［J］. Endocrinology，2007，148（7）：3477-3484
Redox Biol，2020，35：101477 ［38］KERP H，HÖNES G S，TOLSTIK E，et al. Protective ef⁃
［26］VAN DER POL A，VAN GILST W H，VOORS A A，et al. fects of thyroid hormone deprivation on progression of
Treating oxidative stress in heart failure：past，present maladaptive cardiac hypertrophy and heart failure［J］.
and future［J］. Eur J Heart Fail，2019，21（4）：425-435 Front Cardiovasc Med，2021，8：683522
［27］MARTINS D，GARCIA L R，QUEIROZ D A R，et al. Oxi⁃ ［39］PINGITORE A，IERVASI G，FORINI F. Role of the thy⁃
dative stress as a therapeutic target of cardiac remodel⁃ roid system in the dynamic complex network of cardiopro⁃
ing［J］. Antioxidants（Basel），2022，11（12）：2371 tection［J］. Eur Cardiol，2016，11（1）：36-42
［28］HUANG X，LIN X，WANG L，et al. Substitution of ［40］LARSSON S C，MICHAËLSSON K，BURGESS S. IGF⁃1
SERCA2 Cys674 aggravates cardiac fibrosis by promot⁃ and cardiometabolic diseases：a Mendelian randomisation
ing the transformation of cardiac fibroblasts to cardiac study［J］. Diabetologia，2020，63（9）：1775-1782
myofibroblasts［J］. Biochem Pharmacol，2022，203： ［41］YANG Q，HUANG D D，LI D G，et al. Tetramethylpyr⁃
115164 azine exerts a protective effect against injury from acute
［29］ERDAMAR H，DEMIRCI H，YAMAN H，et al. The effect myocardial ischemia by regulating the PI3K/Akt/GSK⁃3β
of hypothyroidism，hyperthyroidism，and their treatment signaling pathway［J］. Cell Mol Biol Lett，2019，24：17
on parameters of oxidative stress and antioxidant status［J］. ［42］WANG Y，ZHANG S. Expression and regulation by thy⁃
Clin Chem Lab Med，2008，46（7）：1004-1010 roid hormone（TH）of zebrafish IGF⁃I gene and amphiox⁃
［30］PAN T，ZHONG M，ZHONG X，et al. Levothyroxine re⁃ us IGFl gene with implication of the origin of TH/IGF sig⁃
placement therapy with vitamin E supplementation pre⁃ naling pathway［J］. Comp Biochem Physiol A Mol Integr
vents oxidative stress and cognitive deficit in experimen⁃ Physiol，2011，160（4）：474-479
tal hypothyroidism［J］. Endocrine，2013，43（2）：434- ［43］XING W，GOVONI K E，DONAHUE L R，et al. Genetic
439 evidence that thyroid hormone is indispensable for prepu⁃
［31］HANNA A，FRANGOGIANNIS N G. Inflammatory cyto⁃ bertal insulin⁃like growth factor⁃I expression and bone ac⁃
kines and chemokines as therapeutic targets in heart fail⁃ quisition in mice［J］. J Bone Miner Res，2012，27（5）：
ure［J］. Cardiovasc Drugs Ther，2020，34（6）：849-863 1067-1079
［32］LIU M，LÓPEZ DE JUAN ABAD B，CHENG K. Cardiac ［44］SCHÜTTE J P，MANKE M⁃C，HEMMEN K，et al. Platelet
fibrosis：myofibroblast ⁃ mediated pathological regulation ⁃derived micrornas regulate cardiac remodeling after myo⁃
and drug delivery strategies［J］. Adv Drug Deliv Rev， cardial ischemia［J］. Circ Res，2023，132（7）：e96-e113
2021，173：504-519 ［45］LIU M N，LUO G，GAO W J，et al. miR⁃29 family：a po⁃
［33］THOMAS T P，GRISANTI L A. The dynamic interplay be⁃ tential therapeutic target for cardiovascular disease［J］.
tween cardiac inflammation and fibrosis［J］. Front Physi⁃ Pharmacol Res，2021，166：105510